Advertisement
Perspective

Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

GeneXpert—A Game-Changer for Tuberculosis Control?

  • Carlton A. Evans mail

    carlton.evans@ifhad.org

    Affiliations: Universidad Peruana Cayetano Heredia, Lima, Peru, Imperial College London Hammersmith Hospital Campus, London, United Kingdom, IFHAD: Innovation For Health And Development, London, United Kingdom

    X
  • Published: July 26, 2011
  • DOI: 10.1371/journal.pmed.1001064

About the Author

Carlton A. Evans
Universidad Peruana Cayetano Heredia, Lima, Peru
Carlton A. Evans
Imperial College London Hammersmith Hospital Campus, London, United Kingdom
Carlton A. Evans
IFHAD: Innovation For Health And Development, London, United Kingdom

Corresponding Author

Email: carlton.evans@ifhad.org

Competing Interests

The author declares that he has no competing interests in relation to this article. He has worked as a consultant for WHO on TB social determinants and for Médecins Sans Frontières on TB infection control and diagnostics, and has received TB-related grants from the Sir Halley Stewart Trust (TB infection control and diagnostics), Imperial Healthcare charities/IFHAD (TB control), the Wellcome Trust (TB susceptibility, infection control, and diagnostics), and FIND (partial support for developing a field TB culture test). None of these funders played any role in the preparation of this article.

Author Contributions

Wrote the first draft: CE. ICMJE criteria for authorship read and met: CE. Agree with the manuscript's results and conclusions: CE.